Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avasopasem Manganese for Oral Mucositis in Head and Neck Cancer
NCT03689712Phase 3Completed
- Sponsor
- Galera Therapeutics, Inc.
- Start
- Oct 2018
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of avasopasem manganese in oral mucositis (OM), sponsored by Galera Therapeutics, Inc.. Started Oct 2018; status: completed.
02
Drugs
avasopasem manganese
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT03689712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03689712.